US Pharm. 2009;34(5):36-38.
The FDA has approved the first generic versions of Topamax (topiramate) tablets to prevent seizures. Topiramate tablets in several different strengths have been approved to be marketed by the following firms: Roxane Laboratories Inc., Par Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Barr Laboratories Inc., Teva Pharmaceuticals USA, Ranbaxy Laboratories Ltd., CIPLA Ltd., Glenmark Generics Ltd., Cobalt Laboratories, Apotex Inc., Zydus Pharmaceuticals USA, Aurobindo Pharma Ltd., Torrent Pharmaceuticals Ltd., Invagen Pharmaceuticals Inc., Unichem Laboratories Ltd., Sun Pharmaceuticals Ltd., and Pliva Hrvatska. Prescribing information, or labeling, for generic topiramate will differ from the innovator drug, as some uses of Topamax continue to be protected by patents and exclusivity.
